DES

(redirected from diethylstilbestrol)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

DES

Abbreviation for "Delivered Ex Ship."

Delivered Ex Ship

In international commerce, an agreement between a buyer and a seller in which the seller must bear all costs and risks of transporting a good until it has arrived at a port and has been made available for the buyer or his/her agent to retrieve it. That is, the seller has total responsibility while the good is being shipped overseas. The seller must pay the shipping company and purchase insurance for the good. See also: Incoterm.
References in periodicals archive ?
1981), Developmental Effects of Diethylstilbestrol (Des) in Pregnancy, New York: Thieme-Stratton.
Bell, "The Synthetic Compound Diethylstilbestrol (DES), 1938-1941: The Social Construction of a Medical Treatment" (Ph.
Acquired lesions are believed to result from pelvic surgery, trauma, curettage, trophoblastic disease, diethylstilbestrol exposure, neoplasm or infection.
Diethylstilbestrol (DES) was the first orally active synthetic estrogen, and its use was intended to facilitate placental steroidogenesis and reduce the risk of spontaneous abortion or preterm parturition in pregnant women (Marselos and Tomatis 1992a, 1992b).
In utero exposure to diethylstilbestrol was associated with a high lifetime risk of a broad spectrum of adverse outcomes in a follow-up study of patients now in their 40s, 50s, and 60s.
Washington, Sept 06 (ANI): Daughters of women who took a synthetic estrogen called diethylstilbestrol (DES) while pregnant decades ago are now facing a greater chance of being infertile and developing cancer, according to a large study by the National Cancer Institute in the United States.
McCarthy's mother if she was given diethylstilbestrol, a synthetic form of estrogen, more commonly known as DES, while pregnant.
transplant recipients or women with HIV) and those who were exposed to diethylstilbestrol (DES) in utero also have a higher risk of developing cervical cancer.
Women aged 30 or older who have had three consecutive normal results can be screened every 3 years if they have no history of cervical intraepithelial neoplasm (CIN) 2 or 3, HIV, immunocompromise, or in utero exposure to diethylstilbestrol.
Medical research indicates that daughters of women who took the drug diethylstilbestrol (DES) anytime from 1938 to 1971 to prevent miscarriage have an increased risk of developing this disease.